Lv6
2930 积分 2023-05-22 加入
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis
1个月前
已完结
Antiviral therapy response in patients with chronic hepatitis B and fatty liver: A systematic review and meta-analysis
1个月前
已关闭
Fibrotic MASH resolutionVCTE index to diagnose fibrotic MASH resolution and predict LREs: A global multicenter study
1个月前
已完结
Glucagon, from past to present: a century of intensive research and controversies
1个月前
已完结
Pre-B-cell leukemia transcription factor 1 contributes to liver fibrosis by enabling IL-7 signaling in HSC
1个月前
已关闭
Vitamin E dosing study (VEDS) in patients with metabolic dysfunction-associated steatotic liver disease with elevated aminotransferases: A multicenter, randomized, placebo-controlled trial
2个月前
已关闭
Risk Stratification of Metabolic Risk Factors and Statin Use Associated With Liver and Nonliver Outcomes in Chronic Hepatitis B
2个月前
已完结
Comparative Hepatic Outcomes of SGLT2i or DPP4i Compared to GLP-1RA in CHB and T2DM Patients
2个月前
已完结
Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease
2个月前
已完结
SGLT2i reduces risk of developing HCC in patients with co-existing type 2 diabetes and hepatitis B infection: A territory-wide cohort study in Hong Kong
2个月前
已完结
皖公网安备34019202002308
